Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Pleskovič, Aleš ^a   Vraspir Porenta, Olga ^b   Zorc Pleskovič, Ruda ^b   Petrovič, Danijel ^b   Zorc, Metka ^b   Milutinović, Aleksandra ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD VESSEL WALL; BODY MASS; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CELL COUNT; CELL DAMAGE; CELL FUNCTION; CELL GRANULE; CELL INFILTRATION; CELL NUCLEUS; CELL STRUCTURE; CELL VACUOLE; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM CELL; EXTRACELLULAR SPACE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE; INTIMA; MALE; MAST CELL; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; STAINING; STEREOLOGY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA; AGED; CHEMISTRY; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; ENDARTERECTOMY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PILOT STUDY; SLOVENIA;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; ENDARTERECTOMY; FIBRIN; FIBRINOGEN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; MALE; MAST CELLS; MIDDLE AGED; PILOT PROJECTS; SLOVENIA; STAINING AND LABELING;

EID: 79955810589     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-40     Document Type: Article

References (26)

1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999, 14(340):115-126.
2. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282. 10.1056/NEJM199705013361802, 9113930.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
4. Kariz S, Milutinovic A, Bregar D, Terzic I, Terzic R, Lovrecic L, Herova M, Hruskovicova H, Peterlin B, Petrovic D, Zorc-Pleskovic R. The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Coll Antropol 2007, 31:503-507.
5. Kariz S, Grabar D, Krkovic M, Osredkar J, Petrovic D. Polymorphisms in the promoter region of the basic fibroblast growth factor gene are not associated with myocardial infarction in a Slovene population with type 2 diabetes. J Int Med Res 2009, 37:1596-1603.
6. Petrovic D, Verhovec R, Globocnik Petrovic M, Osredkar J, Peterlin B. Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology 2007, 107:291-295. 10.1159/000099064, 17264508.
7. Festa A, D'Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51:1131-1137. 10.2337/diabetes.51.4.1131, 11916936.
8. Eriksson EE. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol 2004, 15:553-558. 10.1097/00041433-200410000-00009, 15361791.
9. Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, Fallon JT. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000, 102:2180-2184.
10. Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A. Immunological modulation of human cardiac mast cells. Neurochem Res 1999, 24(9):1195-202. 10.1023/A:1020776807187, 10485592.
11. Constantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92:1083.
12. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004, 146:1-12. 10.1016/j.jneuroim.2003.10.041, 14698841.
13. Bucova M, Bernadic M, Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl Lek Listy 2008, 109:333-340.
14. McNeil HP, Adachi R, Stevens RL. Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J Biol Chem 2007, 282:20785-20789. 10.1074/jbc.R700017200, 17504754.
15. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010, 10:440-452. 10.1038/nri2782, 20498670.
16. Sinkiewicz W. Endogenous heparin - a protective marker in patient with myocardial infartion. Coron Artery Dis 2002, 13:423-426. 10.1097/00019501-200212000-00007, 12544717.
17. Lappalainen H, Laine P, Pentikäinen MO, Sajantila A, Kovanen PT. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004, 24:1880-1885. 10.1161/01.ATV.0000140820.51174.8d, 15284090.
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
19. Vukojevic K, Carev D, Sapunar D, Petrovic D, Saraga-Babic M. Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. J Mol Histol 2008, 39:339-349. 10.1007/s10735-008-9171-4, 18415689.
20. Weibel ER. Stereological methods. Practical Methods for Biological Morphometry. 1979, Academic Press: London.
21. Petrovic D, Zorc M, Zorc-Pleskovic R, Vraspir-Porenta O. Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. Folia Biol (Praha) 1999, 45:63-66.
22. Zhang QY, Ge JB, Chen JZ, Zhu JH, Zhang LH, Lau CP, Tse HF. Mast cell contributes to cardiomyocyte apoptosis after coronary microembolization. J Histochem Cytochem 2006, 54:515-523. 10.1369/jhc.5A6804.2005, 16344327.
23. Metcalfe DD, Boyce JA. Mast cell biology in evolution. J Allergy Clin Immunol 2006, 117:1227-1229. 10.1016/j.jaci.2006.03.031, 16750978.
24. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223. 10.1038/ni.f.216, 2856637, 18936782.
25. Theoharides TC, Rozniecki JJ, Sahagian G, Jocobson S, Kempuraj D, Conti P, Kalogeromitros D. Impact of stress and mast cells on brain metastases. J Neuroimmunol 2008, 205:1-7. 10.1016/j.jneuroim.2008.09.014, 18977036.
26. Han J, Zhang F, Xie J, Linhardt RJ, Hiebert LM. Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin. Cardiovasc Diabetol 2009, 8:46. 10.1186/1475-2840-8-46, 2739842, 19695080.